Pharmaceutical packaging company Wasdell has announced plans to construct a new facility in Dundalk, Ireland.

The new purpose-built facility will be a 70,000ft² self-contained site at the IDA Dundalk Science and Technology Park in Mullagharlin.

From this facility, Wasdell will serve its customers in the pharmaceutical and healthcare sectors.

“We are delighted to have found such an ideal location for our new facility.”

It will offer QC import testing, multiple current and novel packaging technologies, as well as inventory and distribution capabilities.

The company will invest more than €30m to build phase one of the new facility that will occupy a 2.88ha area.

It is also expected to create 300 new jobs over the next five years.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

In addition to providing customer manufacturing solutions, the new site will incorporate serialisation technology to prevent product contamination.

Wasdell Group managing director Martin Tedham said: “We are delighted to have found such an ideal location for our new facility and a special thanks must be given to the Irish Government, the IDA, as well as Louth County Council for their support in making our new site a reality.

“This is an exciting time for our business and will allow us to not only increase our capacity but also extend our operational footprint and the services we are able to offer our client base.”

The facility is expected to become operational in the last quarter of next year.

It will be Wasdell’s first facility outside the UK and allow the company to carry out release testing and necessary packing of the drug products, as well distribute them to Europe and other global locations.